# Correction to: Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis

**Authors:** Ricky Frazer, José Ángel Arranz, Sergio Vázquez Estévez, Omi Parikh, Laura-Maria Krabbe, Naveen S. Vasudev, Christian Doehn, Norbert Marschner, Tom Waddell, Will Ince, Peter J. Goebell

PMC · DOI: 10.1007/s11912-025-01670-6 · Current Oncology Reports · 2025-05-09

## Full-text entities

- **Diseases:** Renal Cell Carcinoma (MESH:D002292)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12227500/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12227500/full.md

---
Source: https://tomesphere.com/paper/PMC12227500